Publications by authors named "Timucin Cil"

Claim this Profile
P
Prognostic and diagnostic value of node-RADS before and after neoadjuvant therapy in locally advanced gastric cancer.
Okan Dilek, Emin Demirel, Kübra Karaaslan Erisen, Zeynep Ozer Ulas, Seyda Gokce Turunc, Timuçin Cil

Eur J Radiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study.
Shun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, Vladimer Kuchava, Aishah Ibrahim, Timucin Cil

Lancet Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.
Maeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, Kai-Keen Shiu, Patricio Yañez

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy.
Yi-Long Wu, Lin Wu, Nan Bi, Timucin Cil, Hong Ge

J Hematol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of body composition in the treatment of locally advanced rectal cancer: the ımpact of adipose and muscle tissue on pathological response.
Okan Dilek, Emin Demırel, Berkay Eyı, Seyda Gokce Turunc, Huseyin Akkaya

Rev Assoc Med Bras (1992)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI.
Ali Ogul, Ali Alper Solmaz, Ilhan Birsenogul, Yunus Coskun, Mahmut Bakır Koyuncu, Timucin Cil

Biomark Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy.
Pinar Peker, Asli Geçgel, Oğuzcan Özkan, Ivo Gökmen, Serkan Menekse

Medicina (Kaunas)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
Mario Campone, Michelino De Laurentiis, Komal Jhaveri, Xichun Hu, Sylvain Ladoire, Timucin Cil

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma.
Ali Alper Solmaz, Ilhan Birsenogul, Aygul Polat Kelle, Pinar Peker, Burcu Arslan Benli, Timucin Cil

Medicina (Kaunas)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer.
Ali Ogul, Ilhan Birsenogul, Aygul Polat Kelle, Ali Alper Solmaz, Yunus Coskun, Timuçin Cil

Rev Assoc Med Bras (1992)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of regorafenib treatment by location and RAS mutation in metastatic colon cancer.
Serdar Ata, Ahmet Gülmez, Tolga Köşeci, Özge Özalp, Timuçin Çil

Medicine (Baltimore)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of halp score in predicting the efficacy of nivolumab treatment in metastatic malignant melanoma patients: A real-life, retrospective, single center analysis.
Serdar Ata, Tolga Köşeci, Burcu Arslan Benli, Ahmet Ziya Bayhan, Oğuzhan Kesen

Medicine (Baltimore)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
Mahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, Hacı Mehmet Türk, Zuhat Urakçı

J Oncol Pharm Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring.
Tolga Köşeci, Mustafa Seyyar, Mehmet Mutlu Kıdı, Sedat Biter, Kadir Eser

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
Thierry André, Elena Elez, Heinz-Josef Lenz, Lars Henrik Jensen, Yann Touchefeu, Timucin Cil

Lancet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study.
Tolga Köşeci, Mustafa Seyyar, Yasemin Aydınalp Camadan, Halil Çelik, Burak Mete

Medicina (Kaunas)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.
Mehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, Omer Tekin, Mehmet Ali Nahit Şendur

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.
Thierry Andre, Elena Elez, Eric Van Cutsem, Lars Henrik Jensen, Jaafar Bennouna, Timucin Cil

N Engl J Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.
Everett E Vokes, Francoise Mornex, Ahmet Sezer, Ying Cheng, Jian Fang, Timucin Cil

J Thorac Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer.
Serdar Ata, Nur Yücel Ekici, Mahmut Büyükşimşek, Timuçin Çil, Berna Bozkurt Duman

Eur Arch Otorhinolaryngol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteral nutrition consensus report from KEPAN: Indications, choice, practical application, and follow-up.
Mutlu Doganay, Kezban Akcay, Timucin Cil, Birgul Dag, Kubilay Demirag

Nutrition· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Sun Young Rha, Do-Youn Oh, Patricio Yañez, Yuxian Bai, Min-Hee Ryu

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.
Likun Chen, Jose David Gomez Rangel, Timucin Cil, Xingya Li, Irfan Cicin

Cancer Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy.
Ahmet Gulmez, Hatice Coskun, Tolga Koseci, Serdar Ata, Berna Bozkurt, Timucin Cil

Medicina (Kaunas)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis